Golem vs Mira — how do they compare? Golem trades at Rp1,569 (market cap Rp1,57T, Rp80,61M 24h volume), while Mira trades at Rp701.98 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Golem is far larger — about 6933.7× Mira's market cap, and Golem's circulating supply is 1B / 1B GLM (100%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Golem for 20 Days and Mira for 22 Days on average.
| GLM | MIRA | |
|---|---|---|
Market Cap | Rp1,57T | Rp226,43M |
Volume (24h) | Rp80,61M | Rp101,47M |
Circulating Supply | 1B / 1B GLM (100%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 20 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Golem (GLM) currently trades at Rp1,562 with a market cap of Rp1.56 trillion, showing bearish technical signals from moving averages despite oversold RSI readings. The token faces immediate resistance at Rp1,600 and support at Rp1,530. With 100% circulating supply and average hold time of 19 days, the network maintains full token distribution but shows relatively short-term holding patterns.
Overall outlook remains cautious with technical weakness prevailing. Key opportunities include potential oversold bounce from current levels, while major risks involve continued bearish momentum and limited fundamental catalysts. Investors should monitor network adoption metrics and trading volume recovery for signs of sustained recovery.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Golem Network is an open-source, decentralized platform that provides computing power for the AI industry. It operates as a peer-to-peer marketplace where users exchange GLM tokens to rent or share idle computing resources.
Read more on GLM →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →